BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22439694)

  • 21. Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials.
    Mulgaonkar A; Venitz J; Gründemann D; Sweet DH
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2705-11. PubMed ID: 23545524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organic cation transporters OCT1 and OCT2 determine the accumulation of lamivudine in CD4 cells of HIV-infected patients.
    Jung N; Lehmann C; Rubbert A; Schömig E; Fätkenheuer G; Hartmann P; Taubert D
    Infection; 2013 Apr; 41(2):379-85. PubMed ID: 22875535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma.
    Geier A; Macias RI; Bettinger D; Weiss J; Bantel H; Jahn D; Al-Abdulla R; Marin JJ
    Oncotarget; 2017 Feb; 8(9):15846-15857. PubMed ID: 28178663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3.
    Sala-Rabanal M; Li DC; Dake GR; Kurata HT; Inyushin M; Skatchkov SN; Nichols CG
    Mol Pharm; 2013 Apr; 10(4):1450-8. PubMed ID: 23458604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
    Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
    Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice.
    Schmitt A; Mössner R; Gossmann A; Fischer IG; Gorboulev V; Murphy DL; Koepsell H; Lesch KP
    J Neurosci Res; 2003 Mar; 71(5):701-9. PubMed ID: 12584728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter in the placenta and fetal tissues: expression profile and fetus protective role at different stages of gestation.
    Ahmadimoghaddam D; Zemankova L; Nachtigal P; Dolezelova E; Neumanova Z; Cerveny L; Ceckova M; Kacerovský M; Micuda S; Staud F
    Biol Reprod; 2013 Mar; 88(3):55. PubMed ID: 23303678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of a Hydrophobic Pocket in Polyamine Interactions with the Polyspecific Organic Cation Transporter OCT3.
    Li DC; Nichols CG; Sala-Rabanal M
    J Biol Chem; 2015 Nov; 290(46):27633-43. PubMed ID: 26405039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins.
    Neul C; Hofmann U; Schaeffeler E; Winter S; Klein K; Giacomini KM; Eichelbaum M; Schwab M; Nies AT
    Br J Pharmacol; 2021 Mar; 178(6):1459-1474. PubMed ID: 33434947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
    Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
    Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.
    Mohelnikova-Duchonova B; Brynychova V; Hlavac V; Kocik M; Oliverius M; Hlavsa J; Honsova E; Mazanec J; Kala Z; Melichar B; Soucek P
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):669-82. PubMed ID: 23934321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multispecific Organic Cation Transporter 1 (OCT1) from Bos taurus Has High Affinity and Slow Binding Kinetics towards Prostaglandin E2.
    He X; Garza D; Nigam SK; Chang G
    PLoS One; 2016; 11(4):e0152969. PubMed ID: 27046168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib.
    Al-Abdulla R; Lozano E; Macias RIR; Monte MJ; Briz O; O'Rourke CJ; Serrano MA; Banales JM; Avila MA; Martinez-Chantar ML; Geier A; Andersen JB; Marin JJG
    Br J Pharmacol; 2019 Mar; 176(6):787-800. PubMed ID: 30592786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
    Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
    Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
    World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.
    Shikata E; Yamamoto R; Takane H; Shigemasa C; Ikeda T; Otsubo K; Ieiri I
    J Hum Genet; 2007; 52(2):117-122. PubMed ID: 17111267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2.
    Gebauer L; Jensen O; Brockmöller J; Dücker C
    J Med Chem; 2022 Sep; 65(18):12403-12416. PubMed ID: 36067397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters.
    Jensen O; Rafehi M; Tzvetkov MV; Brockmöller J
    Biochem Pharmacol; 2020 Jan; 171():113731. PubMed ID: 31783011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
    Nies AT; Koepsell H; Damme K; Schwab M
    Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.